Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
OSL Announcements
OncoSil progresses HDE with US FDA
OSL
ONCOSIL MEDICAL LTD
Market sensitive
OncoSil progresses HDE with US FDA
Date and time
9 June 2026 at 7:48 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001, 14014
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
OSL announcement history
Recent OSL announcements
Change in substantial shareholding from AEF
Application for quotation of securities - OSL
Investor Webinar Presentation
OncoSil Receives FDA Approval for Distal Cholangiocarcinoma
Quarterly Activities/Appendix 4C Cash Flow Report
New Independent Study Confirms OncoSil Dose Flexibility